A 50mg vial of FLGR-242 provides a high-yield lyophilized cake designed specifically for high-throughput preclinical research protocols and extended in vitro assay series. Understanding the exact reconstitution concentration, freeze-thaw management, and lot-matched analytical verification ensures consistent assay reproducibility across extensive experimental runs.
A 50mg vial of FLGR-242 provides a high-yield lyophilized cake designed specifically for high-throughput preclinical research protocols and extended in vitro assay series. Understanding the exact reconstitution concentration, freeze-thaw management, and lot-matched analytical verification ensures consistent assay reproducibility across extensive experimental runs.
The 50mg vial format of FLGR-242 is engineered for laboratory environments that require large mass reserves of synthetic peptides without initiating frequent vial reconstitutions. High-throughput screening (HTS) platforms, automated liquid handlers, and extended cell culture models often draw substantial volumes of working stock. A single 50mg lyophilized vial minimizes vial-to-vial operational variance across multi-well assay plates or longitudinal preclinical animal models.
In laboratory research settings, FLGR-242 is investigated for its molecular interactions with key signaling pathways involved in tissue growth, myostatin regulation, and cellular hypertrophy. When managing a 50mg mass quantity, investigators must handle the lyophilized powder with rigorous sterile technique to maintain sequence integrity across all sub-aliquots. PX1 Research manufactures and packages research-grade peptides under strict atmospheric controls to eliminate moisture pre-seal.
Please note: PX1 Research maintains flexible inventory structures. Standard smaller unit sizes for exploratory assays are indexed on our primary FLGR-242 product page and across our complete catalog of all research peptides. For specialized projects requiring 50mg fills or custom bulk production schedules, research institutions can interface directly with our institutional division through our wholesale lab portal.
Reconstituting a 50mg lyophilized cake requires precise solvent calculations due to the high mass concentration. Depending on the assay parameters, researchers can adjust the diluent volume (typically sterile Bacteriostatic Water or sterile 0.9% Sodium Chloride) to reach target stock concentrations. Using an automated reconstitution calculator prevents manual volumetric errors prior to pipetting.
When adding 1.0 mL of reconstituting diluent to a 50mg vial, the final yield is a highly concentrated stock of 50.0 mg/mL (equivalent to 50.0 µg per microliter). This ultra-dense concentration is optimal for high-density master mixes or micro-dispensing applications where fluid addition volumes must be kept extremely small to avoid diluting culture media.
If a 2.0 mL diluent volume is introduced, the resulting working stock concentration is 25.0 mg/mL (25.0 µg/µL). At 3.0 mL of diluent volume, the concentration decreases to 16.67 mg/mL (16.67 µg/µL). For laboratories utilizing standard multi-channel pipettes calibrated for 5.0 mL vial expansions, adding 5.0 mL yields a standardized 10.0 mg/mL working concentration. Regardless of diluent volume, solvent should always be directed gently down the inner glass vial wall rather than sprayed directly onto the peptide cake to prevent shear stress.
Because 50mg represents a substantial mass quantity for single-use laboratory applications, repeated freeze-thaw cycles of the primary reconstituted stock must be avoided. Degradation of the peptide chain can occur through repeated mechanical stress during phase transitions between frozen solid and liquid states.
Immediately following full dissolution, the primary stock should be divided into single-use or single-assay micro-aliquots using sterile, low-binding polypropylene microcentrifuge tubes. Pre-calculating the exact mass needed per experimental microplate allows researchers to thaw only the specific micro-aliquots required for that day's protocol.
Aliquoting protocols should be conducted within a certified Class II Biosafety Cabinet (BSC) to maintain sterility. Micro-aliquots should be labeled with the compound identifier, original lot number, reconstituted concentration, and date of preparation prior to flash-freezing or immediate placement into -20°C or -80°C storage units.
Every batch of FLGR-242 distributed by PX1 Research undergoes rigorous third-party analytical testing to confirm compound identity, structural integrity, and high purity. Researchers can verify their specific lot specifications by downloading documentation directly from our COA lookup system.
High-Performance Liquid Chromatography (HPLC) is employed to determine chemical purity, ensuring that the primary target peak accounts for ≥98% of the relative area under the curve (AUC). Impurities such as truncated peptide sequences or residual synthesis byproducts are clearly quantified and reported on the analytical certificate.
Mass Spectrometry (MS) confirms the exact molecular weight of the synthetic peptide matching its theoretical mass. Furthermore, total endotoxin testing via Limulus Amebocyte Lysate (LAL) assay ensures that endotoxin levels remain below strictly defined laboratory limits (<0.05 EU/mg), protecting sensitive cell lines and animal models from confounding inflammatory responses.
In cell biology and musculoskeletal signaling research, FLGR-242 is evaluated alongside several other high-affinity signaling modulators. Broadening laboratory inquiries across related compounds allows researchers to map receptor affinity curves and differential pathway activation across varied tissue models.
For example, researchers exploring myostatin binding pathways frequently compare FLGR-242 against established peptides such as Follistatin-344, which exhibits broad-spectrum activin and myostatin neutralizing activity. Similarly, investigate structural variants such as ACE-031, a soluble activin receptor type IIB (ActRIIB) fusion protein studied for its decoy receptor properties.
Another relevant compound within growth-pathway research is IGF-1 LR3, which operates through distinct receptor tyrosine kinase pathways to influence protein synthesis and cellular proliferation. Cross-referencing these compounds provides a broader understanding of how distinct peptide architecture influences intracellular downstream signaling cascades in vitro.
Prior to reconstitution, the 50mg lyophilized cake of FLGR-242 exhibits superior physical stability when stored under controlled low-temperature conditions. Lyophilization removes unbound water, preventing hydrolysis reactions that degrade peptide bonds over time.
Unopened lyophilized vials should be stored at -20°C for short-to-medium term storage (up to 12 months) or -80°C for long-term storage repositories. The storage container should be kept in a desiccated environment to prevent atmospheric moisture accumulation on the outer vial surface during retrieval.
Once reconstituted into aqueous solution, the chemical stability window decreases. Reconstituted solutions maintained at 2°C to 8°C should be utilized within 14 to 21 days depending on the choice of diluent (e.g., bacteriostatic preservative vs. unpreserved sterile water). Frozen reconstituted aliquots stored at -20°C maintain structural stability for up to 3 to 6 months, provided they undergo zero freeze-thaw cycles.
Selecting between a 50mg high-yield vial and smaller standard options (such as 5mg or 10mg vials) depends entirely on your project's operational scale and handling capabilities. Large bulk fills offer administrative convenience and reduce packaging volume for high-volume screens.
However, if your research design involves low-frequency testing, sporadic pilot assays, or multi-site preliminary screens, utilizing smaller vial formats reduces the risk of accidental stock degradation caused by long liquid-phase storage times.
Reviewing study timelines, total volume requirements, and pipette precision limits will guide the decision. For further background on experimental design considerations across our catalog, explore our centralized research library hub.
PX1 Research operates as a premier supplier dedicated exclusively to supporting the scientific community. Every peptide lot is synthesized in GMP-compliant facilities within the United States, utilizing automated solid-phase peptide synthesis (SPPS) methodologies.
Our quality control protocols incorporate independent verification by accredited ISO 17025 testing laboratories. We maintain strict lot-to-lot consistency so that researchers obtain reproducible experimental data across multi-year study timelines.
All orders ship rapidly from our centralized fulfillment centers in California and Arizona. Fast, temperature-monitored logistics ensure that heat-sensitive research compounds arrive at your laboratory facility without compromising bioactivity.
What is the concentration of FLGR-242 50mg reconstituted with 2mL of diluent?
Reconstituting a 50mg vial with 2.0 mL of sterile diluent produces a stock solution with a concentration of 25.0 mg/mL (25.0 µg/µL).
Is FLGR-242 50mg available directly in the standard PX1 online catalog?
Standard catalog sizes are listed on our FLGR-242 product page. For 50mg vials or custom batch sizes, institutional research teams can place custom orders via our wholesale lab account program.
How should reconstituted FLGR-242 50mg aliquots be stored?
Reconstituted liquid stock should be divided into single-use polypropylene aliquots and stored at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles.
Where can I find the lot-specific Certificate of Analysis for my vial?
You can verify your specific batch purity, HPLC chromatograms, mass spec results, and endotoxin reports by entering your lot number into our online COA lookup tool.
What diluent is recommended for laboratory reconstitution of FLGR-242?
Sterile Bacteriostatic Water (containing 0.9% benzyl alcohol) is standard for multi-use working stocks stored at 2-8°C, while sterile 0.9% saline or sterile water may be used for immediate single-assay applications.
What analytical purity level does PX1 Research guarantee for FLGR-242?
PX1 Research guarantees a minimum of ≥98% chemical purity for FLGR-242 as verified by third-party HPLC analysis.
Can FLGR-242 be used for clinical or veterinary applications?
No. All compounds supplied by PX1 Research, including FLGR-242, are intended strictly for in vitro and preclinical laboratory research applications by qualified investigators.
What is the endotoxin limit for PX1 Research peptides?
PX1 Research peptides undergo LAL endotoxin testing to ensure levels remain strictly below <0.05 EU/mg, protecting cellular culture assays from endotoxin interference.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.